Bart Corsaro

Countries

This corpus build does not record which country the citing authors are in, so the country breakdown is not computed. The other breakdowns below are unaffected.

Institutions

• Pfizer (United States)20.1%
• Takeda (United States)9.4%
• Peking University8.3%
• Peking University Cancer Hospital8.3%
• South African Medical Research Council7.6%
• Bristol-Myers Squibb (United States)6.7%
• Other39.7%

Fields

• Medicine50.7%
• Immunology and Microbiology28.8%
• Biochemistry, Genetics and Molecular Biology17.8%
• Engineering1.4%
• Pharmacology, Toxicology and Pharmaceutics1.4%

Topics

• Biosimilars and Bioanalytical Methods14.2%
• Neonatal and Maternal Infections13.5%
• CAR-T cell therapy research12.8%
• Streptococcal Infections and Treatments10.8%
• Pneumonia and Respiratory Infections9.5%
• Virus-based gene therapy research6.8%
• Other32.4%